Law ❯ Litigation ❯ Class Action ❯ Securities Fraud

False Statements

Multiple Law Firms Seek Lead Plaintiffs in Erasca Securities Suit Ahead of August 10 Deadline

The solicitations target shareholders from the January 14, 2025–April 26, 2026 class period to pursue claims that Erasca misrepresented its ERAS-0015 program and exposed the company to patent risk.

7 ARTICLES

2mo ago

Multiple Firms Seek Lead Role in Gossamer Bio Securities Suit After PROSERA Miss

10 ARTICLES

3mo ago

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

12 ARTICLES

4mo ago

ImmunityBio Files FDA Response on Anktiva Ads as Investor Suits Build

4 ARTICLES

5mo ago

BellRing Investors Urged to Seek Lead-Plaintiff Status as March 23 Deadline Nears

3 ARTICLES

6mo ago

Law Firms Seek Lead Plaintiffs in Ramaco Securities Case Over Brook Mine Disclosures

3 ARTICLES

6mo ago

Vistagen Investors Urged to Seek Lead Plaintiff Role in Securities Suit as March 16 Deadline Nears

6 ARTICLES

7mo ago

Inspire Medical Faces Securities Class Action Over Inspire V Rollout as Lead‑Plaintiff Deadline Nears

5 ARTICLES

8mo ago

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

11 ARTICLES

9mo ago

CarMax Securities Class Period Extended to Nov. 5 as Firms Press Jan. 2 Lead-Plaintiff Deadline